Intacs For Keratoconus – Suzanne Corcoran, COE
Intacs were approved by the FDA in 1999 for treatment of mild myopia and astigmatism. In July 2004, the manufacturer received a Humanitarian Device Exemption for the use of Intacs to treat keratoconus in patients who no longer achieve adequate functional vision with contact lenses or eyeglasses. This procedure helps to restore functional vision and potentially defers the need for a corneal transplant procedure. Surgical treatment of keratoconus with Intacs is reversible and less invasive than penetrating keratoplasty (PK). Recovery time is faster, and the cost is considerably lower. Patients may even be able to wear contact lenses again. PK at a later time is not precluded, if it becomes necessary.
To view the entire article in Ophthalmology Management click on the link below: